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INTRODUCTION
Hearing impairment is the most common sensory disorder in hu-
mans. It occurs in one in 1,000 newborns and genetic causes are
estimated to cause more than 50% of all incidents of congenital
hearing loss in children. Genetic hearing impairment is a highly
heterogeneous disorder, in which about 70% of cases are non-syn-
dromic. It can follow a pattern of autosomal dominant, autosomal
or X-linked recessive transmission, or mitochondrial inheritance (1).
To date, more than 120 loci for nonsyndromic hearing loss
(NSHL) have been mapped in the human genome and approxi-
mately 47 genes have been identified as causative genes by means
of the positional cloning (Hereditary Hearing Loss Homepage; http:
//webh01.ua.ac.be/hhh/). Among these genes, GJB2, SLC26A4
and mitochondrial 12S rRNA genes have been extensively stud-
ied in many studies and the spectrum and frequencies of mutations
vary in different ethnic populations (2-4). Despite the fact that
large number of known rare mutations in these genes has been
reported, mutation hot spots were also found to be race-specif-
ic. For example, 235delC for GJB2 and H723R for SLC26A4 are
the most frequent mutations in East Asians (5-7). Also, the frequen-
cy of mtDNA A1555G mutation is dependent on racial or geo-
graphic origins and the frequency estimate is 1.4% for Koreans (8).
DNA microarrays, sometimes called DNA chips, are designed
to allow many hybridization experiments to be performed at a
time. A large number of DNA probes, each one with a different
sequence, are immobilized at defined positions on a solid surface.
The probes can be synthetic oligonucleotides or other short DNA
molecules such as cDNAs. The array is incubated with labeled
target DNA to allow hybridization to take place. Which oligonu-
cleotides have hybridized to the target DNA is determined by
scanning the surface of the array and recording the positions at
which the signal emitted by the label is detectable and software
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Original Articletools are used for data extraction and analysis. Conventional
gel- based or direct sequencing analysis has been used to screen
known deafness genes, but these methods are time-consuming and
expensive. Because specific mutations have showed the pattern
of high frequency mutations in diverse populations, the demand
for rapid and cheap genetic analysis has risen sharply. For this
purpose, the DNA microarray is a method that offers simultane-
ous screening for a large number of specific mutations in known
genes and makes it meaningful to initially select hotspot muta-
tions for neonatal screening or the genetic testing of a genetically
heterogeneous condition such as deafness. In this study, we
have developed a genetic hearing loss DNA chip that allows the
simultaneous analysis of 7 different mutations in regards to the
GJB2, SLC26A4, and the mtDNA 12S rRNA genes.
MATERIALS AND METHODS
DNA samples
Various previously genotyped five patients and five control DNA
samples were provided by the Department of Otorhinolaryngo-
logy-Head and Neck Surgery, Kyungpook National University
Hospital. All participants provided written informed consent ac-
cording to the protocol approved by the Ethics Committee of Ky-
ungpook National University Hospital prior to the study.
Polymerase chain reaction (PCR) amplification
Genomic DNA was extracted from peripheral blood using Flexi-
Gene DNA extraction kit (QIAGEN, Hilden, Germany), or from
buccal swab specimens by using Puregene Buccal Cell Core Kit
A (QIAGEN).
All PCR reactions were performed in a 25 μ L volume contain-
ing 1× PCR buffer (Solgent, Daejeon, Korea), 10 mM deoxynu-
cleotide triphosphate (dNTP), 10 pmol each of forward and reverse
oligonucleotide primers, 1U/μ L of Taq DNA polymerase (Solgent),
and 25 ng genomic DNA. The parameters for PCR consisted of
a denaturation cycle at 95℃ for 2 min, followed by 30 cycles at
94℃ for 30 sec, 57℃ for 30 sec, 72℃ for 30 sec, a final exten-
sion cycle at 72℃ for 5 min, and a stabilization step at 4℃. PCR
was performed using a PTC-200 thermal cycler and an iCycler
TM‚
Thermal cycler (BIO-RAD, Hercules, CA, USA). For purification
of the PCR products, an ExoSAP IT Kit (USB Corp., Cleveland,
OH, USA) was used.
Genotyping and data analysis
The principle of allele specific primer extension (ASPE) reaction
is described in Fig. 1. In brief, an ASPE reaction consisted of 5
mL of pooled PCR products, specific normal and mutant primer
mixes, cy5-dUTP, i-starTaq DNA polymerase (iNtRON Biothn-
ology, Seongnam, Korea). A total of 20 μ L of pooled ASPE reac-
tion was suspended in 50 μ L hybridization buffer (5× SSC, 0.1%
SDS, 25 mg/mL Cot-1 DNA, 25% formamide, 0.5 mg/mL polyA,
10% dextran sulfate). After being heated for 5 min at 95℃, the
hybridization mixture was added to the DNA chip. The slide was
incubated at 45℃ for 30 min and washed once at 50℃ in 2×
SSC, 0.1% SDS for 10 min and four times at room temperature in
0.1× SSC for 1 min. The DNA chip was scanned in an GenePix
4000B scanner (Axon, Union City, CA, USA) and the data was
incorporated into the Microsoft Excel program (Microsoft Corp.,
Redmond, WA, USA).
RESULTS
Based on the previous studies in Korea, a genetic hearing loss
DNA chip was designed in order to detect the following changes:
the GJB2 V37I, R143W, and 235delC; the SLC26A4 IVS7-2A
>G, IVS9+3A>G, and H723R; the mtDNA A1555G mutation
(Table 1) (5, 8-11). Thirty five mer of cZipCode sequences with
10 nucleotides spacer (CAGGCCAAGTCT) adjacent to the 5′ -end
were printed as the probes on the DNA chip as illustrated in Fig.
2. All Zipcode sequences were selected from the database and
bioinformatics’ tools and designed to hybridize with the com-
plementary ASPE reaction product on the microarray. Allele-




Table 1. The contents of genetic hearing loss chip used in this study
V37I Connexin26 GJB2 Kelley et al. (12), Snoeckx et al. (13)
R143W Connexin26 GJB2 Brobby et al. (14)
235delC Connexin26 GJB2 Park et al. (11), Dai et al. (15)
A1555G 12S rRNA MTRNR1 Bae et al. (8)
IVS7-2A>G Pendrin SLC26A4 Coucke et al. (16), Park et al. (6)
IVS9+3A>G Pendrin SLC26A4 Park et al. (5)
H723R Pendrin SLC26A4 Usami et al. (17), Park et al. (6)
SNP: single nudeotide polymorphism.
Fig. 1. The principle of allele-specific primer extension (ASPE).  ASPE
is a solution based, sequence specific enzymatic reaction technolo-
gy that can be used to assay multiple SNPs in a single tube. A primer
anneals and is expended if there is a perfect match at the SNP site. The
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specific oligonucleotides to the normal and mutant sequences
linked to the 25 mer of ZipCode at the 5′ end were synthesized
to enable an accurate discrimination of a nucleotide substitution
in the designated position.
We have validated the genetic hearing loss DNA chip from five
patients with a total of six sequence mutations and five controls,
with the exception of the R143W mutation, which were previous-
ly confirmed as the genotypes of each mutation by DNA sequenc-
ing analysis. Since no subject with R143W mutation was identi-
fied in our samples, only normal controls were used for DNA chip
validation purposes. Of the five sequence mutations, two were
in the GJB2 gene, two in SLC26A4 gene, and one in mitochon-
drial 12S rRNA genes. Genotype index (GI) was quantitated from
the spot intensities of 10 μ m pixel size in the scanner using the red
Cy5 channel (635 nm). Using the background subtracted medi-
an pixel intensity as the spot value (SV), the GI for each normal
and mutant spot pair was calculated by the following program,
GI=SVnormal/(SVnormal+SVmutant) (18). Cutoff GI values for
genotypes for each mutation were justified, as shown in Table 2,
and applied for the genotyping on the DNA chip. 
Representative results of the current DNA chip are presented
in Fig. 3. Fig. 3A shows the normal control genotypes that were
homozygous for wild-type. In contrast, the DNA chip assay showed
the homozygote and heterozygote for 235delC mutation of GJB2
gene and the homozygote and heterozygote for H723R mutation
for SLC26A4 gene (Fig. 3B, C). The result of DNA chip assay was
identical to those of DNA sequencing analysis demonstrating on
a clear distinction between the homozygous and heterozygous
mutation.
DISCUSSION
Genetic hearing loss is a highly heterogeneous disorder, in which
a number of genes cause the same phenotype. Over the last few
decades, mutations within the prevalent three genes, GJB2, SLC
26A4, and mitochondrial 12S rRNA genes have been extensive-
ly reported across many populations and are currently recognized
as being the most common deafness genes. Moreover, the muta-
tion spectra and frequencies in these genes have been demonstrat-
ed to be dependent on each population. Recently, Han et al. (9)




Table 2. Genotype index values used to determine genotype for the
7 mutations
V37I 0.00-0.35 0.40-0.68 0.80-1.00
R143W* 0.00-0.31 0.41-0.67 0.80-1.00
235delC 0.00-0.35 0.40-0.65 0.80-1.00
A1555G 0.00-0.30 0.65-1.00
IVS7-2A>G 0.00-0.30 0.40-0.60 0.70-1.00
IVS9+3A>G 0.00-0.30 0.40-0.60 0.70-1.00
H723R 0.00-0.35 0.40-0.50 0.70-1.00
*GI value of R143W mutation from Siemering et al. (18).
Fig. 2. Layout of the genetic hearing loss DNA chip. Oligonucleotides









IVS9+3A>G_N IVS9+3A>G_M 235delC_N 235delC_M
Fig. 3. Examples of hybridization results. The genotype indexes calculated from the hybridization signals of mutant spots are also shown.
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population were identified in 3% of the newborns with normal
hearing and V37I mutation was the most common, followed by
235delC mutation (9, 13). SLC26A4 gene associated with enlarged
vestibular aquaduct (EVA) also accounts for as much as 10% of
hereditary hearing loss in diverse populations. In our population,
5 different mutation alleles are detected in most of patients with
the clinical symptom of EVA (5). Especially, the haplotype analy-
sis has shown that 235delC in the GJB2 gene and H723R in the
SLC26A4 gene are common founder mutations, indicating that
the ethnic background should be considered when performing
genetic testing (6, 7, 17). In addition, the mtDNA A1555G muta-
tion has been identified as the most prevalent mitochondrial muta-
tion (19). Although the prevalence of this mutation in Koreans
was lower than those of other Asians, it is still considered as the
most frequent mutation out of the mtDNA genes (8).
Early diagnosis of the genetic etiology for congenital hearing
loss expedites early intervention and aids in management deci-
sions and genetic counseling. However, routine mutation analy-
sis of patients suffering from hearing loss has been hampered by
the high costs associated with application of conventional analy-
sis techniques. Recently, microarray approach has been exten-
sively used for analyzing the expression levels of thousands of
genes and for doing multiplex genotyping of SNPs and large-scale
mutation screening. For the HL, several studies using microarray
have proposed for high-throughput mutation screening of deaf-
ness genes and demonstrated accurate and reliable results (18,
20, 21). Since some mutations on the mutation panels have only
identified in Caucasians and vice versa, genetic screening based
on the mutation spectrum of a corresponding population may be
an appropriate and effective strategy for detecting mutations in
causative genes.
In this study, we first designed a chip-based genotyping strat-
egy according to the principle of single nucleotide ASPE reaction
and were successfully able to simultaneously screen 7 mutations
in three causative genes for hearing loss in Korea. This DNA chip-
based assay will provides a relatively rapid and cost-effective for
mutation detection in clinical genetic diagnosis. Further consid-
eration will need to examine the accuracy of this DNA chip with
much larger numbers of patient samples.
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